gvhd
Showing 1 - 25 of 30
GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)
Not yet recruiting
- GVHD
- Acute Stem Cell Transplant Complications
-
Chendu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 3, 2023
GVHD, GVHD, Undefined Trial in United States (Photobiomodulation Therapy, Placebo sham device)
Recruiting
- Graft-Versus-Host Disease
- +2 more
- Photobiomodulation Therapy
- Placebo sham device
-
Bethesda, Maryland
- +8 more
Jan 17, 2023
Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia Trial (Blood sample taken at a single time point)
Not yet recruiting
- Autoimmune Diseases
- +10 more
- Blood sample taken at a single time point
- (no location specified)
Sep 14, 2022
GVHD Trial in Hackensack (Telmisartan)
Active, not recruiting
- GVHD
-
Hackensack, New JerseyHackensack University Medical Center
Sep 2, 2022
Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)
Active, not recruiting
- Graft Vs Host Disease
- GVHD
- Pacritinib
- +2 more
-
Tampa, Florida
- +1 more
Jul 27, 2022
GVHD, GVHD, Acute-graft-versus-host Disease Trial in Canada, United States (Itolizumab, EQ001 Placebo)
Recruiting
- Graft Versus Host Disease
- +4 more
- Itolizumab
- EQ001 Placebo
-
Duarte, California
- +5 more
Jul 5, 2022
GVHD Trial in New York (Bortezomib, Cyclophosphamide)
Active, not recruiting
- GVHD
-
New York, New YorkNew York University School of Medicine
Apr 15, 2022
Ocular Surface Disease in Chronic Graft-Versus-Host Disease
Recruiting
- Dry Eye
- GVHD
- Cross-sectional study
-
Singapore, SingaporeCynthia Boo
Mar 22, 2022
GVHD, Hematologic Tumors Trial in La Jolla (Cyclophosphamide, abatacept, Methotrexate)
Recruiting
- GVHD
- Hematologic Neoplasms
- Cyclophosphamide
- +3 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Mar 21, 2022
GVHD Trial (FMT)
Not yet recruiting
- GVHD
- FMT
- (no location specified)
Oct 15, 2021
Acute-graft-versus-host Disease, aGVHD, GVHD Trial in United States (EQ001, EQ001 Placebo)
Recruiting
- Acute-graft-versus-host Disease
- +3 more
- EQ001
- EQ001 Placebo
-
Duarte, California
- +18 more
Oct 1, 2021
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)
Completed
- Graft Versus Host Disease
- GVHD
- Panobinostat
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021
Graft-versus-host-disease, GVHD Trial in United States (Alpha 1-Antitrypsin)
Completed
- Graft-versus-host-disease
- GVHD
- Alpha 1-Antitrypsin
-
Duarte, California
- +4 more
Jun 17, 2021
GVHD Trial in Minneapolis (CelluTome® Epidermal Harvesting System)
Withdrawn
- GVHD
- CelluTome® Epidermal Harvesting System
-
Minneapolis, MinnesotaUniversity of Minnesota
Apr 15, 2021
GVHD, Bone Marrow Transplant Failure, Alpha 1-Antitrypsin Trial in Israel
Active, not recruiting
- GVHD
- +2 more
-
Jerusalem, Center, Israel
- +3 more
Mar 9, 2021
Leukemia, Lymphoma, MDS Trial in Moscow (CD45RA-depleted peripheral blood mononuclear cells)
Unknown status
- Leukemia
- +5 more
- CD45RA-depleted peripheral blood mononuclear cells
-
Moscow, Russian FederationFederal Research Center for pediatric hematology, oncology and i
Feb 5, 2020
After Allogeneic Hematopoietic Stem Cell Transplantation
Completed
- Allogeneic Stem Cell Transplantation
- GVHD
-
Bologna, ItalyMario Arpinati
Jan 17, 2019
Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients
Completed
- Cytomegalovirus Infection
- GVHD
-
Regensburg, GermanyUniversitätsklinikum Regensburg
Aug 7, 2018
Graft-vs-Host Disease, GVHD Trial in Boston (Brentuximab Vedotin)
Terminated
- Graft-vs-Host Disease
- GVHD
- Brentuximab Vedotin
-
Boston, MassachusettsMassachusetts General Hospital
Jul 23, 2018